Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Calaway

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Oncologist|August 19, 2025
Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin and Pembrolizumab: A Path to Cure?Albert Jang, Nikita Tripathi, Sree M Lanka, et al.
Urology|July 19, 2025
Increasing Utilization of Sedation for Prostate Biopsies: National Trends, Predictors, and Patient CostCamilo Arenas-Gallo, Mollie Goldman, Jack C Millot, et al.
Bladder Cancer (Amsterdam, Netherlands)|September 22, 2025
Genetic susceptibility and environmental risk factors in bladder cancer: Evidence from the UK biobankLaura Bukavina, Ilaha Isali, Sneha Parekh, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-Institutional Prospective Cohort EvaluationLaura Bukavina, Rashida Ginwala, Mohit Sindhani, et al.
Urologic Oncology|June 19, 2026
Geospatial correlation of industrial plastics emissions with bladder and kidney cancer burden in OhioDevika Nandwana, Jayant Siva, Laura Davis, et al.
Cancer Research Communications|May 15, 2024
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort EvaluationLaura Bukavina, Rashida Ginwala, Mohamed Eltoukhi, et al.
Kidney Cancer (Clifton, Va.)|July 1, 2025
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trialsAlbert Jang, Jeffrey Y Zhong, Hamsa L S Kumar, et al.
Clinical Genitourinary Cancer|January 13, 2026
Non-Immunotherapy Arm Allocations in Phase 3 Genitourinary Cancer Trials with ImmunotherapyAbby L Grier, Albert Jang, Jeffrey Y Zhong, et al.
Urologic Oncology|November 8, 2020
"Robotic fatigue?" - The impact of case order on positive surgical margins in robotic-assisted laparoscopic prostatectomyLaura Bukavina, Kirtishri Mishra, Amr Mahran, et al.
JAMA Oncology|November 20, 2025
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-AnalysisNicholas G Zaorsky, Yilun Sun, Abdenour Nabid, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Oncologist|August 19, 2025
Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin and Pembrolizumab: A Path to Cure?Albert Jang, Nikita Tripathi, Sree M Lanka, et al.
Urology|July 19, 2025
Increasing Utilization of Sedation for Prostate Biopsies: National Trends, Predictors, and Patient CostCamilo Arenas-Gallo, Mollie Goldman, Jack C Millot, et al.
Bladder Cancer (Amsterdam, Netherlands)|September 22, 2025
Genetic susceptibility and environmental risk factors in bladder cancer: Evidence from the UK biobankLaura Bukavina, Ilaha Isali, Sneha Parekh, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-Institutional Prospective Cohort EvaluationLaura Bukavina, Rashida Ginwala, Mohit Sindhani, et al.
Urologic Oncology|June 19, 2026
Geospatial correlation of industrial plastics emissions with bladder and kidney cancer burden in OhioDevika Nandwana, Jayant Siva, Laura Davis, et al.
Cancer Research Communications|May 15, 2024
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort EvaluationLaura Bukavina, Rashida Ginwala, Mohamed Eltoukhi, et al.
Kidney Cancer (Clifton, Va.)|July 1, 2025
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trialsAlbert Jang, Jeffrey Y Zhong, Hamsa L S Kumar, et al.
Clinical Genitourinary Cancer|January 13, 2026
Non-Immunotherapy Arm Allocations in Phase 3 Genitourinary Cancer Trials with ImmunotherapyAbby L Grier, Albert Jang, Jeffrey Y Zhong, et al.
Urologic Oncology|November 8, 2020
"Robotic fatigue?" - The impact of case order on positive surgical margins in robotic-assisted laparoscopic prostatectomyLaura Bukavina, Kirtishri Mishra, Amr Mahran, et al.
JAMA Oncology|November 20, 2025
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-AnalysisNicholas G Zaorsky, Yilun Sun, Abdenour Nabid, et al.
Pageof 5